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Acetylationa b s t r a c t
By using acetyl-CoA as a substrate, acetyltransferases and histone deacetylases regulate protein
acetylation by adding or removing an acetyl group on lysines. Nuclear-located Hdac1 is a regulator
of intestinal homeostasis. We have previously shown that Hdac1 define specific intestinal epithelial
cell basal and inflammatory-dependent gene expression patterns and control cell proliferation. We
show here that Hdac1 depletion in cellulo leads to increased histone acetylation after metabolic
stresses, and to metabolic disturbances resulting in impaired responses to oxidative stresses,
AMPK kinase activation and mitochondrial biogenesis. Thus, nuclear Hdac1 may control intestinal
epithelial cell metabolism by regulating the supply of acetyl groups.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction [10]. Thus, cell energy-dependent variations of acetyl-CoA levelsProtein acetylation is a major post-translational modification
regulated by acetyltransferases and deacetylases (HDAC), which
respectively add or remove an acetyl group on lysine residues
[1]. In addition to histones, many nuclear, cytoplasmic and mito-
chondrial proteins are acetylated, forming the acetylome [2].
Acetylation of histones relaxes DNA-histone interactions and cre-
ates binding sites for bromodomain-containing proteins, which
affect chromatin structure and gene expression [1]. Acetylation of
non-histone proteins modifies protein functions by altering protein
interactions with other proteins or DNA, as well as protein stability
and location [3,4]. Protein acetylation is a highly regulated process
dependent on cell metabolites. Indeed, protein acetylation levels
are dependent in part on the regulation of HDAC activity by
endogenous HDAC inhibitors such as sphingosine-1-phosphate
[5], b-hydroxybutyrate [6,7] and carnitine [8], whose levels vary
with cell metabolism. Furthermore, histone acetylation depends
on the availability of the substrate acetyl-CoA in nuclear and cyto-
plasmic compartments [9,10]. For example, citrate produced from
glucose metabolism, through the Krebs cycle, is used by the ATP-
citrate lyase (ACL) for acetyl-CoA production. ACL depletion leads
to both reduced acetyl-CoA cellular levels and histone acetylationor HDAC-inhibiting metabolites may lead to alterations in the
acetylome as well as epigenetic signalling.
Members of the HDAC family are divided in three classes,
including nuclear class I enzymes with zinc-dependent HDAC
activity, and mitochondrial or nuclear sirtuins with NAD+-
dependent activity [1]. Hdac1 is a class I HDAC, which, together
with Hdac2, forms homo- or heterodimers in various transcrip-
tional multiprotein regulators such as NuRD, Sin3A and CoREST
[11,12]. Hdacl deficiency in mice leads to embryonic death and cell
proliferation defects correlating with increased levels of the cyclin-
dependent kinase inhibitor p21 [13,14]. Tissue-specific ablation of
both Hdacl and Hdac2 leads to differentiation defects in many
organs, including the brain [15], the skin [16] and the intestine
[17]. Hdac1 represses or activates both global and specific gene
expression programs. For example, while Hdac1 acts as a co-
activator for glucocorticoid-dependent gene regulation [18], Hdac1
is considered a negative regulator of NF-jB-dependent transcrip-
tional inflammatory responses by deacetylating the p65 subunit
[19]. Hdac1 is associated mostly with active genes and may allow
multiple rounds of transcription by clearing promoters of acety-
lated histone marks [20]. Finally, we have recently shown that
Hdacl may play an important role in establishing and maintaining
defined ranges of IL-1b-dependent inflammatory gene expression
in intestinal epithelial cells (IEC) [21].
We have recently shown that Hdac1 reduction by continuous
expression of specific shRNAs against Hdac1 reduces proliferation
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Interestingly, this growth defect was not associated with increased
expression of cyclin-dependent kinase inhibitors usually aug-
mented in response to HDAC inhibitors or to specific HDAC isoform
siRNA-mediated depletion in tumour cell lines [22]. In this study,
we provide evidence that Hdac1 reduction indirectly alters cell
proliferation by compromising metabolic pathways essential for
cell growth. Indeed, Hdac1 depletion leads to modified cell
responses to metabolites and oxidative stresses, correlating with
the induction of the AMPK signalling pathway and mitochondrial
biogenesis. Reduction in acetyl group availability, caused by Hdac1
depletion, may well lead indirectly to metabolic pathway disrup-
tion, explaining the severe growth inhibition effect.2. Materials and methods
2.1. Cell culture
Non-transformed and undifferentiated IEC-6 cells are derived
from rat intestinal crypts (CRL-1592, ATCC) [23]. Cells were grown
in Dulbecco’s modified Eagle medium (DMEM) with 5% fetal bovine
serum (FBS). Confluent shCtrl and shHDAC1 IEC-6 cells were cul-
tured in medium without or with 5% FBS and glucose, in normal
medium without or with citrate (10 mM) or acetate (10 mM)
(Sigma–Aldrich). In some experiments, cells were treated with
5 lM of the class I inhibitor MS-275 (Cayman), 250 lM H2O2,
500 lM of the AMPK activator AICAR (Cayman) or 10 lM AMPK
inhibitor compound C (Biovision).
2.2. Retroviral infection
ShCtrl and shHDAC1 cell lines were obtained after puromycin
selection of IEC-6 cells with lentiviral shRNA control (SHC002V)
or MISSION shRNA HDAC1 (TRCN0000039402) particles (Sigma–
Aldrich). This particular shRNA, and the corresponding cell clones,
was selected out of three shRNA constructs for Hdac1 reduction
levels and growth inhibitory properties [21].
2.3. Western blot analysis
ShCtrl and shHDAC1 IEC-6 cells were resuspended in Laemmli
buffer [24], to obtain total cell protein extracts. Nuclei were pre-
pared as before [25,26] and resuspended in Laemmli buffer. Protein
concentrationswere determinedby theBCAmethod (ThermoScien-
tific). Proteins loaded on a 6%, 10% or 15% SDS–polyacrylamide gel
were electroblottedonaPVDFmembrane (Roche).Membraneswere
incubated1 hat roomtemperature,with the followingprimaryanti-
bodies: rabbit anti-Hdac1 (Abcam Inc.); murine anti-actin (EMD
Millipore); rabbit anti-histone H3ac and anti-histone H4ac (EMD
Millipore); rabbit anti-H3K9ac, -H4K5ac and -H3K56ac (Cell
Signalling); goat anti-H4K16ac (Epigentek); rabbit anti-Sod2
(GeneTex); rabbit anti-phospho-AMPK (Thr172), -AMPK, -phospho-
acetyl-CoA carboxylase (ACC) (Ser79) (Cell Signalling) [25,26].
Immune complexes were detected with Amersham ECLTM Western
blotting detection reagents (GE Healthcare), according to the
manufacturer’s instructions. PonceauRed stainingwasused todetect
relativeamounts ofhistones innuclearextracts. Results are represen-
tative of three independent experiments. Additional information
about the antibodies used is included in Table S1.
2.4. SILAC labelling, quantification and bioinformatic analysis
Quantitative analysis of protein content was performed after
stable isotope labelling with amino acids (SILAC). ShCtrl and
shHDAC1 IEC-6 cells were grown in DMEM without arginine andlysine, supplemented with 5% FBS dialyzed with a cut-off of
10kDa (Life Technologies). Arginine and lysine were added in
either light (Arg0, Lys0; Sigma–Aldrich) or heavy isotopes (Arg10,
Lys8; Cambridge Isotope Lab) to a final concentration of 28 lg/ml
arginine and 49 lg/ml lysine, respectively for shCtrl and shHDAC1
IEC-6 cells, during six passages. Whole cell lysates from triplicates
of each condition were mixed, subjected to detergent removal,
alkylation and trypsin digestion. Digested peptides were used for
liquid chromatography–tandem mass spectrometry, data analysis
with the MaxQuant program (version 1.1.1.14) and peptide
identification with the Andromeda database, as done before [27].
Proteins with shHDAC1 over shCtrl ratios of more than 1.5-fold
and less than 0.75-fold were selected for classification according
to their gene Ontology biological processes, with the Ingenuity
pathway database (http://www.ingenuity.com). The mass spectrom-
etry proteomics data have been deposited to the ProteomeXchange
Consortium (http://proteomecentral.proteomexchange.org) via the
PRIDE Partner repository.
2.5. Cell viability measurement
To determine cell viability, fifty thousand shCtrl and shHDAC1
IEC-6 cells were plated in each well. 24 h later, the medium was
replaced by medium without or with serum and glucose, or H2O2.
The next day, 50 ll of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphe
nyltetrazolium bromide, 0.5 mg/ml) (Sigma–Aldrich) were added
to each well for 2 h at 37 C. The culture medium was removed
before adding 100 ll of acid-isopropanol solution to solubilise
water-insoluble formazan crystals. Optical density was determined
on a Versamax ELISA microplate reader at 550 nm (Molecular
Devices). Results are expressed as the mean ± S.E.M. Statistical sig-
nificance was determined by performing one-way ANOVA. Results
are representative of three independent experiments.
2.6. Reactive oxygen species (ROS) measurement
ROS production was measured with the DCFDA Cellular ROS
Detection Assay Kit (Abcam) in a 96-well microplate. Ten thousand
shCtrl and shHDAC1 IEC-6 cells were plated in each well. After
24 h, cells were incubated in normal medium supplemented with
25 lM of 20,70-dichlorofluorescein diacetate (DCFDA) at 37 C for
45 min. After washing, cells were incubated for 3 h at 37 C, in nor-
mal medium without or with 500 lM H2O2 freshly prepared. ROS
concentrations were determined in a microplate reader at a
485 nm excitation wavelength and a 535 nm emission wavelength.
Results are expressed as the mean ± S.E.M. Statistical significance
was determined by performing one-way ANOVA. Results are repre-
sentative of three independent experiments.
2.7. ATP assays
Ten thousand shCtrl and shHDAC1 IEC-6 cells were plated in
each well. The following day, an equal volume of ATP assay solu-
tion (PhosphoWorks Luminometric ATP Assay Kit *Study Glow*,
AAT Bioquest) was added to each well for 10 min at room temper-
ature. ATP concentration was determined by reading flash lumi-
nescence for 1 s with an Orion Microplate Luminometer
(Berthold Technologies). The experiment was done three times in
triplicate. Results are expressed as the mean ± S.E.M. Statistical sig-
nificance was determined by performing unpaired t tests.
2.8. Mitochondria labelling
Mitochondria were labelled with the Cell NavigatorTM Mitochon-
drion Staining Kit (AAT Bioquest). Ten thousand cells were placed
in a LAB-TEK (Thermo Fisher Scientific). After 24 h, cells were
Fig. 1. Hdac1 depletion affects IEC-6 cell metabolite-dependent histone acetylation. IEC-6 shCtrl and shHDAC1 cells were cultured for 24 h in normal medium, in medium
without serum and glucose, in normal medium with added citrate, acetate and class I HDAC inhibitor MS-275. Nuclear extracts were resuspended in Laemmli buffer. Nuclear
proteins were separated on a 15% SDS–PAGE gel and transferred to PVDF membranes for Western blot analysis of total acetylated H3 (H3 ac.) and acetylated H4 (H4 ac.).
Ponceau Red staining was used to detect relative amounts of histones in nuclear extracts. Experiments were performed in triplicate and results from one representative blot
are shown.
Table 1
Pathway analysis of decreased and induced proteins in shHDAC1 depleted IEC-6 cells.
Hdac1 depletion leads to altered expression of mitochondrial and mTOR pathway
proteins. More than 1.5-fold or less than 0.75-fold induced or repressed proteins in
shHDAC1 depleted IEC-6 cells were selected for the analysis. Pathway analysis of
decreased and induced proteins in shHDAC1 depleted IEC-6 cells was done according
to biological processes identified with the Ingenuity pathway database. The top
canonical pathway induced and the top canonical pathway decreased, are indicated.
Name P-value Ratio
Top canonical pathway induced
Mitochondrial dysfunction 6,96E17 27/215
Isoleucine degradation 8,08E09 07/30
Oxidative phosphorylation 4,50E08 14/120
Valine degradation I 1,08E06 06/35
Top canonical pathway decreased
EIF2 signalling 2,68E19 37/201
Regulation of eIF4 and p70S6K signalling 2,39E13 27/175
mTOR signalling 5,92E10 26/213
Protein ubiquitination pathway 4,35E09 29/270
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ing Buffers for 4 h at 37 C. The buffer was then replaced with PBS.
Mitochondria were observed with an Inverse Zeiss Fluorescence
Microscope (Carl Zeiss) at a 40 magnification and FITC filter set
of Ex/Em = 485/525 nm, with 500 ms time of exposition. Images
were generated with the AxioVision software (Carl Zeiss).
2.9. qPCR analysis
2 ng of cDNAs, prepared from shCtrl and shHDAC1 IEC-6 cell
mRNAs, were used for qPCR using the RT2 SYBR Green ROX qPCR
Master Mix (Qiagen), and oligonucleotides against selected mito-
chondrial nuclear-expressed genes, namely Tfb2m, Tfam, Aldh2,
Idh2 and Atp5O (Table S1). Relative quantification was assessed
by Tbp amplification. Ten min incubation at 95 C was followed
by 40 cycles of 10 s at 95 C, 10 s at 60 C and 20 s at 72 C. Results
are expressed as the mean ± S.E.M. Statistical significance was
determined by performing unpaired t tests. Results are representa-
tive of two independent experiments.
3. Results and discussion
We have previously shown that shRNA-dependent Hdac1
reduction (21, Fig. S1) led to a cyclin-dependent kinase inhibitor-
independent decrease in IEC-6 cell proliferation [21]. In order to
determine how Hdac1 depletion affected IEC-6 cell growth, we first
verified the impact of Hdac1 depletion on global histone acetyla-
tion in IEC-6 cells. ShCtrl and shHDAC1 cells were grown in med-
ium without glucose and serum, in medium supplemented with
acetyl-CoA donors citrate and acetate, or in medium containing
the HDAC class I Hdac1, Hdac2 and Hdac3 deacetylase inhibitor
MS-275. As shown by Wellen et al. [10], absence of glucose and
serum resulted in decreased levels of acetylated histone H3 and
H4 in shCtrl cells (Fig. 1) and of site-specific acetylated marks
H3K9ac, H3K56ac, H4K5ac and H4K16ac (Fig. S2). In contrast, his-
tone acetylated levels were maintained in shHDAC1 cells, even in
the absence of glucose and serum (Figs. 1 and S2). This indicates
that Hdac1 plays an important role in the turnover of histone
acetyl groups in response to metabolic disturbances. Acetateaddition led to stronger increases in histone acetylation, notably
of H4, in shHDAC1 cells as compared to shCtrl cells grown in nor-
mal medium (Figs. 1 and S2). This suggests that Hdac1 depletion
increases steady-state levels of histone acetylation resulting from
acetyl-CoA donor addition, by decreasing turnover efficiency. How-
ever, other class I enzymes are involved in this turnover, as MS-275
led to increased histone acetylated levels in both shCtrl and
shHDAC1 cells (Figs. 1 and S2). Thus, these data suggest that Hdac1
regulates global histone acetylation levels in IEC-6 cells. In addi-
tion, acetylated histone levels are more increased in the absence
of Hdac1, as opposed to control cells, in conditions when acetyl-
CoA production is increased. Thus, Hdac1 depletion, by reducing
the availability of acetyl groups for metabolic reactions, could
impact on cell growth by altering metabolic responses in IEC-6
cells.
To determine the phenotypic changes resulting from Hdac1
depletion, we analysed the proteome of shCtrl and shHDAC1 IEC-
6 cells by differential labelling with light and heavy isotopes of
arginine and lysine, with the SILAC method [27,28]. We separately
analysed upregulated and downregulated proteins in shHDAC1
Table 2
Metabolic pathway disturbances in shHDAC1 depleted IEC-6 cells. Metabolic pathway alterations resulting from Hdac1 reduction in IEC-6 cells are represented as a bar graph
with up and downregulated pathways of metabolic processes, such as respectively, degradation pathways and synthesis processes. Pathway analysis of decreased and induced
proteins was done according to biological processes identified with the Ingenuity pathway database.
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Fig. 2. (A–C) Hdac1 depletion leads to altered IEC-6 cell responses to oxidative stress. (A) Expression levels of Sod2 and Pbgd, as a loading control, were determined by
quantitative PCR of cDNAs obtained from total shCtrl and shHDAC1 IEC-6 RNAs. Results represent the mean ± S.E.M. (**P 6 0.01). Statistical significance was determined by
unpaired t tests (left panel). ShCtrl and shHDAC1 IEC-6 cells were cultured for 24 h in medium with or without serum and glucose. Cells were resuspended in Laemmli buffer.
Total proteins were analysed for Sod2 and actin, as a protein loading control, by Western blot. Experiments were performed in triplicate and results from one representative
experiment are shown (right panel). (B and C) ShCtrl (B) and shHDAC1 (C) IEC-6 cells in 24-well plates were cultured for 24 h in medium with 250 lM hydrogen peroxide.
Cells were labelled for 2 h with MTT to evaluate cell viability. Graphics were created with GraphPad Prism software and statistics determined by ANOVA test (**P 6 0.01;
***P 6 0.005). The experiment was performed in triplicate and results of a representative experiment are shown. (D) Hdac1 depletion leads to reduction of reactive oxygen
radical production. ShCtrl and shHDAC1 IEC-6 cells in 24-well plates were treated with DCFDA for 45 min, before adding 500 lM hydrogen peroxide for 3 h. Relative amounts
of free radicals were measured by spectrofluorimetry. Graphics were created with GraphPad Prism software and statistics determined by ANOVA test (*P 6 0.05; **P 6 0.01).
The experiment was performed in triplicate and the results of a representative experiment are shown.
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main altered categories were related to energy metabolism.
Indeed, the Top induced canonical pathways included Mitochon-
drial Dysfunction, Isoleucine Valine Degradation and Oxidative
Phosphorylation (P-value from 6,96E17 to 4,5E08) (Table 1).The Top decreased canonical pathways were related to protein
synthesis and cell energy sensing, and included EIF2 Signalling,
Regulation of eIF4 and p70S6K Signalling, mTOR Signalling and
Protein Ubiquitination Pathway (P-value from 2,68E19 to
4,3E09). Proteins increased more than 1.5-fold in the
Fig. 3. Hdac1 depletion leads to increases of basal and induced levels of AMPK
phosphorylation correlating with decreased ATP production. (A) ShCtrl and
shHDAC1 IEC-6 cells were cultured for 2 or 8 h in medium containing AICAR
(upper panel) or for 24 h in medium with or without serum and glucose, or in
complete medium containing AICAR or compound C (lower panel). Cells were
resuspended in Laemmli buffer. Total proteins were analysed for phospho-ACC,
phospho-AMPKa, AMPKa and actin, as a protein loading control, by Western blot.
Experiments were performed in triplicate and results from one representative
experiment are shown. (B) Ten thousand shCtrl and shHDAC1 IEC-6 cells were
grown in 96-well-plates and ATP was measured with a Luciferase ATP assay kit.
Statistical significance was determined by unpaired t tests (****P 6 0.001).
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than 1.5-fold in the Protein Synthesis pathway are listed in
Table S3. Closer analysis of the altered metabolic pathways showed
downregulation of ARNt charging, correlating with increased
amino acid degradation pathways, including valine and isoleucine
(Table 2). In addition, lipid b-oxidation and acetyl-CoA biosynthe-
sis pathways were increased. This suggests that Hdac1 depletion
leads to a reduction of normal metabolic processes and to induc-
tion of degradation pathways to supply metabolites necessary to
ensure cell viability. Again, this coincides with altered mitochon-
drial function and mTOR energy sensing signalling upon Hdac1
depletion. This is intriguing since the Hdac1 deacetylase is mostly
a nuclear protein, with predominantly nuclear substrates [11,29].
As proteome analysis revealed an increase of proteins associ-
ated with mitochondria and oxidative responses, we first verified
the expression of superoxide dismutase 2 (Sod2), an antioxidant
protein with manganese-dependent activity [30], whose protein
expression is increased 7,4-fold in shHDAC1 cells (Table S3). QPCR
analysis confirmed induced expression at the mRNA level (Fig. 2A).
In addition, basal Sod2 protein levels were increased in shHDAC1
cells, as opposed to shCtrl cells, independently of energy-
deficient cell culture conditions (Fig. 2A). We then determined
whether Hdac1 reduction affected IEC-6 viability in medium
depleted of glucose and serum, by MTT assay. Hdac1 depleted cellsdisplayed increased viability. Indeed, cell viability was reduced by
23% for shHDACl cells (P < 0.05), instead of 46% for shCtrl cells
(P < 0.0001). The same was observed in response to the oxidant
H2O2: shCtrl cells were twofold more sensitive than shHDAC1 cells
to oxidative stress induced by H2O2 (Fig. 2B and C). We then mea-
sured the relative amounts of reactive oxygen species (ROS) after
loading cells with DCFDA, whose accumulation correlates with
ROS levels. ShHDAC1 cells displayed decreased basal as well as
H2O2-mediated ROS levels, as opposed to shCtrl cells (Fig. 2D).
Proteomic analysis also revealed possible perturbations in cell
energy levels. To determine this, we assessed the activity of AMPK,
a major energy cell sensor of AMP to ATP concentrations [31].
AMPK is allosterically activated by AMP, leading to promotion of
ATP-generating metabolic reactions and reduction of ATP-
consuming anabolic pathways regulated in part by mTOR.
ShHDAC1 cells displayed increased basal activation of AMPKa, as
assessed by Western blot analysis with an antibody against a phos-
phorylated form, as well as increased phosphorylation of the
AMPKa substrate ACC (Fig. 3A).
While the AMPK inhibitor compound C reduced AMPKa phos-
phorylation in both cell types, treatment with the AMPK activator
AICAR led to increased AMPKa activation in shHDACl and shCtrl
cells. Moreover, shHDAC1 cells produced less ATP, as opposed to
shCtrl cells, suggesting an increase in the levels of the AMPKa acti-
vator, namely AMP (Fig. 3B). These results suggest that Hdac1
depletion leads to metabolic alterations resulting in restriction of
energy metabolism and sustained activation of AMPKa, a negative
regulator of the mTOR pathway. As our proteome analysis sug-
gested mitochondrial alterations and as AMPKa regulation of mito-
chondrial biogenesis may be related in part to constitutive AMPK
activation [32], we verified mitochondrial content by fluorescent
labelling. Microscopy analysis shows that Hdac1 depleted cells
were enlarged, with bigger nuclei, and contained increased num-
bers of mitochondria (Fig. 4A). Increased mRNA expression of
genes associated with mitochondria, such as Tfb2m, Aldh2, Idh2
and Atp5O, as assessed by qPCR, confirmed increased mitochon-
drial biogenesis (Fig. 4B).
It has been proposed that changes in epigenetic regulator activ-
ities, by reducing the availability of cellular metabolites, could
influence metabolic pathways and cell homeostasis, as well as gene
expression patterns [33]. We show here that depletion in a nuclear
deacetylase, namely Hdac1, in intestinal epithelial cells, results in
metabolic changes associated with ATP energy source depletion,
with altered responses to metabolic substrates and oxidative stres-
ses, and impaired increased activation of AMPKa, accompanied
with mitochondrial biogenesis. These observations are supported
by recent studies, one showing that depletion of Sin3A, which is
a component of a Hdac1-containing co-repressor complex [12],
alters mitochondrial activity in Drosophila cells [34], the other
showing that class I HDAC inhibitors increase mitochondrial bio-
genesis in cultured myotubes and adipocytes [35]. We suggest that
the absence of nuclear Hdac1 may indirectly alter cellular metabo-
lism and energy levels by restricting the availability of acetyl
groups for acetyl-CoA, or other metabolite, production, therefore
decreasing their availability for metabolic reactions. Indeed, lim-
ited removal of the acetyl groups on histones occurs in the absence
of Hdac1, even in conditions lowering the acetylated mark, such as
in low glucose conditions, as reported by Wellen et al. [10].
Increased retention of the acetyl group on histones could lead to
decreased ATP production, increased AMPK activation and mito-
chondrial biogenesis, thereby favoring the use of other energy
sources. Our results suggest that Hdac1 depletion may alter meta-
bolic pathways, leading to different responses to metabolic
changes, and affecting in part the oxidative response.
Fig. 4. Hdac1 depletion leads to increased mitochondrial biogenesis. (A) Ten thousand cells plated in a LAB-TEK were treated with a combination of MitoliteTM Green and Live Cell
Staining Buffers to stain mitochondria. Cell mitochondria were observed with an Inverse Zeiss Fluorescence Microscope at a 40 magnification and FITC filter set of Ex/Em = 485/
525 nm, with 500 ms time of exposition. Images were generatedwith the AxioVision software. (B) Total RNAs were isolated from shCtrl and shHDAC1 IEC-6 cells. Relative expression
levels of selected mitochondria-associated genes, namely Tfb2m, Tfam, Aldh2, Atp5O and Idh2, were verified by quantitative PCR, with Tbp as a loading control. Results represent the
mean ± S.E.M. (*P6 0.05). Statistical significance was determined by unpaired t tests.
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